Literature DB >> 3043452

Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas.

G M Brodeur1, C T Fong, M Morita, R Griffith, F A Hayes, R C Seeger.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3043452

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  8 in total

1.  In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei.

Authors:  A Valent; J Bénard; B Clausse; M Barrois; D Valteau-Couanet; M J Terrier-Lacombe; B Spengler; A Bernheim
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

2.  Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.

Authors:  C T Fong; N C Dracopoli; P S White; P T Merrill; R C Griffith; D E Housman; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 3.  Biology of tumors of the peripheral nervous system.

Authors:  G M Brodeur; J F Moley
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

4.  Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.

Authors:  Chao Li; Jian Zhang; Suyun Chen; Shuo Huang; Shuqi Wu; Linlin Zhang; Fengxian Zhang; Hui Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-07       Impact factor: 9.236

Review 5.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

6.  ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.

Authors:  Annica Wilzén; Cecilia Krona; Baldur Sveinbjörnsson; Erik Kristiansson; Daniel Dalevi; Ingrid Øra; Katleen De Preter; Raymond L Stallings; John Maris; Rogier Versteeg; Staffan Nilsson; Per Kogner; Frida Abel
Journal:  Mol Cancer       Date:  2013-07-08       Impact factor: 27.401

7.  Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.

Authors:  N K Foreman; D R Rill; E Coustan-Smith; E C Douglass; M K Brenner
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

8.  Systematic computational identification of prognostic cytogenetic markers in neuroblastoma.

Authors:  Chao Qin; Xiaoyan He; Yanding Zhao; Chun-Yip Tong; Kenneth Y Zhu; Yongqi Sun; Chao Cheng
Journal:  BMC Med Genomics       Date:  2019-12-12       Impact factor: 3.063
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.